Discover why Edgewise Therapeutics, Inc. is rated Buy amid strong trial data, unique HCM treatment, and major 2026 catalysts. Click for this EWTX update.

Detailed price information for Dyne Therapeutics Inc (DYN-Q) from The Globe and Mail including charting and trades.

Biopharma may see a happier year ahead in 2026 than in recent years, according to analysts at William Blair. For one thing, the industry’s top stocks have recovered from lows that stretched into last ...

The film “Lilly,” released in spring of 2025, tells the story of Lilly Ledbetter, the Jacksonville, Ala., native who famously ...

Myotonic dystrophy type 1 (DM1) is the most common form of adult-onset muscular dystrophy, affecting about 1 in 8,000 people. While it is well known for causing muscle weakness and stiffness, DM1 also ...

Contractor Click has officially launched its Concrete Coating Accelerator Program, a specialized initiative designed to assist epoxy flooring and concrete coating contractors in enhancing their lead ...

Precision BioSciences offers high-risk, high-reward potential, trading below cash with key HBV and DMD data catalysts ...

Imagine if everyone treated fertility the way they do heart health: checking it regularly, interpreting data early and taking ...

Deborah Johnson recalled drawing a picture for a magazine art contest while growing up. "A friend mailed it in, and I got response that I was too young for the art school," she said. "I wasn’t ...

New research suggests that exercise may not just make us feel younger—it could actually slow or even reverse the body’s molecular clock. By looking at DNA markers of aging, scientists found that ...